AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

181.990

+3.3101.85%

Volume:1.41M

Turnover:253.99M

Market Cap:87.16B

PE:-23.69

High:181.990

Open:178.500

Low:178.010

Close:178.680

52wk High:216.734

52wk Low:88.830

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.47

T/O Rate:0.29%

Dividend:4.19

Dividend Rate:2.30%

EPS(TTM):-7.681

EPS(LYR):-7.680

ROE:-15.83%

ROA:7.26%

PB:4.10

PE(LYR):-23.70

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+0.85%

Pharmaceutical Companies+1.34%

ESG Concept-0.47%

Capital Flow

Inflow:

Outflow:

News

CSL (ASX:CSL) Backs Lixudebart As Investors Ask If The Undervalued View Still Holds

Simply Wall St.

CSL's Alentis Licensing Deal Low-Risk, Low-Reward, RBC Capital Markets Says

MT Newswires Live

Prices Us$1,000 Mln 10-Year Notes at 6.201% Fixed Rate Coupon

THOMSON REUTERS

Settlement of Notes Expected on October 14, 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CSL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":181.99,"timestamp":1791349920000,"preClose":178.68,"halted":0,"volume":1408941,"delay":0,"changeRate":0.018524736959928376,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.680002411284813,"marketStatus":"Not Yet Opened","change":3.31,"latestTime":"10-07 16:12:00 AEDT","open":178.5,"high":181.99,"low":178.01,"amount":253991643,"amplitude":0.022274,"askPrice":182,"askSize":4172,"bidPrice":181.2,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-7.680002411284813,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":178.68,"dividendRate":0.022371,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":1.4691211990918183,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":178.68,"auctionPrice":181.95,"auctionVolume":339014,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349803595}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.680006,"volumeRatio":1.4691211990918183,"shares":478911979,"dividePrice":4.191704,"high":181.99,"amplitude":0.022274,"preClose":178.68,"low":178.01,"week52Low":88.83,"pbRate":"4.10","psRate":"3.84","week52High":216.734,"institutionHeld":0,"latestPrice":181.99,"committee":-0.985721,"eps":-7.681215134924076,"divideRate":0.023033,"volume":1408941,"delay":0,"ttmEps":-7.681215134924076,"open":178.5,"prevYearClose":168.21,"prevWeekClose":175.35,"prevMonthClose":184.22,"prevQuarterClose":184.22,"fiveDayClose":184.22,"twentyDayClose":171.21,"sixtyDayClose":120.175,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673019013","title":"CSL (ASX:CSL) Backs Lixudebart As Investors Ask If The Undervalued View Still Holds","url":"https://stock-news.laohu8.com/highlight/detail?id=2673019013","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673019013?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:38","pubTimestamp":1791383882,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) has entered into an exclusive partnership with Alentis Therapeutics to co-develop lixudebart, supporting the antibody with a US$355 million upfront payment and up to US$1.2 billion in potential milestone payments.\nCSL shares have been on a strong run recently, with the 90 day share price return of 44.98% and 30 day share price return of 5.09% suggesting momentum has picked up after a weaker patch. This comes even though the 1 year total shareholder return is still down 9.23% and...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/881503-card/1789585842930","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/881503-card/1789585842930"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-backs-lixudebart-as-investors-ask-if-the-underval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-backs-lixudebart-as-investors-ask-if-the-underval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BK7511","BK7508","ISBC","BK7067","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673671490","title":"CSL's Alentis Licensing Deal Low-Risk, Low-Reward, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673671490","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673671490?lang=en_us&edition=fundamental","pubTime":"2026-10-07 12:10","pubTimestamp":1791346251,"startTime":"0","endTime":"0","summary":"CSL's  deal with Alentis Therapeutics for Lixudebart, a therapy candidate for anti-neutrophil cytoplasmic antibodies-associated vasculitis and rapidly progressive glomerulonephritis, is low-risk but low-reward, RBC Capital Markets said in a Thursday note.It noted that the clinical and commercial aspects of Lixudebart are unknown and the timeframe to first potential commercial revenues is fairly long. The deal's PoS adjusted net present value is AU$415 million.RBC reduced CSL's earnings per share forecasts by 0.1% to 0.4% for fiscal 2027 to fiscal 2029.The brokerage assigned an outperform rating to CSL and raised the price target to AU$215 from AU$213.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LU0029864427.USD","LU0310800379.SGD","LU0708994859.HKD","LU1267930573.SGD","GSIB","BK7501","BK4207","CSL.AU","LU0128525929.USD","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673662090","title":"Prices Us$1,000 Mln 10-Year Notes at 6.201% Fixed Rate Coupon","url":"https://stock-news.laohu8.com/highlight/detail?id=2673662090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673662090?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:24","pubTimestamp":1791325479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUE6JFKDF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7067","BK7508","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673306620","title":"Settlement of Notes Expected on October 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673306620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673306620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:24","pubTimestamp":1791325479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUE6JFKDF:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CSL.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.008453},{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.013363},{"market":"AU","name":"ESG Concept","id":"package_au_concept_esggn","bkCode":"BK7511","changeRate":-0.004706}]}}